Have a personal or library account? Click to login
In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery Cover

In vitro evaluation of stearylamine cationic nanoemulsions for improved ocular drug delivery

Open Access
|Oct 2019

References

  1. 1. S. Tamilvanan and S. Benita, The potential of lipid emulsion for ocular delivery of lipophilic drugs, Eur. J. Pharm. Biopharm.58 (2004) 357–368; https://doi.org/10.1016/J.EJPB.2004.03.03310.1016/j.ejpb.2004.03.033
  2. 2. F. Lallemand, P. Daull, S. Benita, R. Buggage and J.-S. Garrigue, Successfully improving ocular drug delivery using the cationic nanoemulsion, Novasorb, J. Drug Deliv.2012 (2012) 604204; https://doi.org/10.1155/2012/60420410.1155/2012/604204
  3. 3. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today18 (2013) 290–297; https://doi.org/10.1016/J.DRUDIS.2012.10.00510.1016/j.drudis.2012.10.005
  4. 4. C. Maïssa, M. Guillon, P. Simmons and J. Vehige, Effect of castor oil emulsion eyedrops on tear film composition and stability, Contact Lens Anterior Eye33 (2010) 76–82; https://doi.org/10.1016/j.clae.2009.10.00510.1016/j.clae.2009.10.005
  5. 5. A. Manosroi, K. Podjanasoonthon and J. Manosroi, Development of novel topical tranexamic acid liposome formulations, Int. J. Pharm.235 (2002) 61–70; https://doi.org/10.1016/S0378-5173(01)00980-210.1016/S0378-5173(01)00980-2
  6. 6. S. C. de Araújo, A. C. A. de Mattos, H. F. Teixeira, P. M. Z. Coelho, D. L. Nelson and M. C. de Oliveira, Improvement of in vitro efficacy of a novel schistosomicidal drug by incorporation into nanoemulsions, Int. J. Pharm.337 (2007) 307–315; https://doi.org/10.1016/J.IJPHARM.2007.01.00910.1016/j.ijpharm.2007.01.009
  7. 7. M. Fraga, M. Laux, B. Zandoná, G. R. Santos, C. dos Santos Giuberti, M. C. de Oliveira, U. Matte and H. Ferreira Teixeira, Optimization of stearylamine-based nanoemulsions obtained by spontaneous emulsification process as nucleic acids delivery systems, J. Drug Deliv. Sci. Technol.18 (2008) 398–403; https://doi.org/10.1016/S1773-2247(08)50078-510.1016/S1773-2247(08)50078-5
  8. 8. S. H. Klang, J. Frucht-Pery, A. Hoffman and S. Benita, Physicochemical characterization and acute toxicity evaluation of a positively-charged submicron emulsion vehicle, J. Pharm. Pharmacol.46 (1994) 986–993; https://doi.org/10.1111/j.2042-7158.1994.tb03254.x10.1111/j.2042-7158.1994.tb03254.x
  9. 9. I. A. Sogias, A. C. Williams and V. V Khutoryanskiy, Why is chitosan mucoadhesive?, Biomacro-molecules9 (2008) 1837–1842; https://doi.org/10.1021/bm800276d10.1021/bm800276d
  10. 10. W. T. Liau and A. M. Kasko, Poly(methyl 6-acryloyl-β-d-glucosaminoside) as a cationic glycomimetic of chitosan, Biomacromolecules18 (2017) 4133–4140; https://doi.org/10.1021/acs.biomac.7b0119110.1021/acs.biomac.7b01191
  11. 11. M. Juretić, B. Jurišić Dukovski, I. Krtalić, S. Reichl, B. Cetina-Čižmek, J. Filipović-Grčić, J. Lovrić and I. Pepić, HCE-T cell-based permeability model: A well-maintained or a highly variable barrier phenotype?, Eur. J. Pharm. Sci.104 (2017) 23–30; https://doi.org/10.1016/J.EJPS.2017.03.01810.1016/j.ejps.2017.03.018
  12. 12. M. Juretić, B. Cetina-Čižmek, J. Filipović-Grčić, A. Hafner, J. Lovrić and I. Pepić, Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models, Eur. J. Pharm. Sci.120 (2018) 133–141; https://doi.org/10.1016/J.EJPS.2018.04.03210.1016/j.ejps.2018.04.032
  13. 13. K. Kinnunen, A. Kauppinen, N. Piippo, A. Koistinen, E. Toropainen and K. Kaarniranta, Cationorm shows good tolerability on human HCE-2 corneal epithelial cell cultures, Exp. Eye Res.120 (2014) 82–89; https://doi.org/10.1016/J.EXER.2014.01.00610.1016/j.exer.2014.01.006
  14. 14. A. Pauly, M. Meloni, F. Brignole-Baudouin, J.-M. Warnet and C. Baudouin, Multiple endpoint analysis of the 3D-reconstituted corneal epithelium after treatment with benzalkonium chloride: Early detection of toxic damage, Invest. Ophthalmol. Vis. Sci.50 (2009) 1644–1652; Retrieved from http://dx.doi.org/10.1167/iovs.08-299210.1167/iovs.08-2992
  15. 15. I. Pereira de Sousa, C. Steiner, M. Schmutzler, M. D. Wilcox, G. J. Veldhuis, J. P. Pearson, C. W. Huck, W. Salvenmoser and A. Bernkop-Schnürch, Mucus permeating carriers: formulation and characterization of highly densely charged nanoparticles, Eur. J. Pharm. Biopharm.97 (2015) 273–279; https://doi.org/10.1016/J.EJPB.2014.12.02410.1016/j.ejpb.2014.12.024
  16. 16. Y. Singh, J. G. Meher, K. Raval, F. A. Khan, M. Chaurasia, N. K. Jain and M. K. Chourasia, Nanoemulsion: Concepts, development and applications in drug delivery, J. Control. Release252 (2017) 28–49; https://doi.org/10.1016/j.jconrel.2017.03.00810.1016/j.jconrel.2017.03.008
  17. 17. V. K. Rai, N. Mishra, K. S. Yadav and N. P. Yadav, Nanoemulsion as pharmaceutical carrier for dermal and transdermal drug delivery: Formulation development, stability issues, basic considerations and applications, J. Control. Release270 (2018) 203–225; https://doi.org/10.1016/J.JCONREL.2017.11.04910.1016/j.jconrel.2017.11.049
  18. 18. S. M. Đorđević, A. Santrač, N. D. Cekić, B. D. Marković, B. Divović, T. M. Ilić, M. M. Savić and S. D. Savić, Parenteral nanoemulsions of risperidone for enhanced brain delivery in acute psychosis: Physicochemical and in vivo performances, Int. J. Pharm.533 (2017) 421–430; https://doi.org/10.1016/J.IJPHARM.2017.05.05110.1016/j.ijpharm.2017.05.051
  19. 19. L. Gan, J. Wang, M. Jiang, H. Bartlett, D. Ouyang, F. Eperjesi, J. Liu and Y. Gan, Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers, Drug Discov. Today18 (2013) 290–297; https://doi.org/10.1016/J.DRUDIS.2012.10.00510.1016/j.drudis.2012.10.005
  20. 20. R. L. Walenga, A. H. Babiskin, X. Zhang, M. Absar, L. Zhao and R. A. Lionberger, Impact of Vehicle Physicochemical Properties on Modeling-Based Predictions of Cyclosporine Ophthalmic Emulsion Bioavailability and Tear Film Breakup Time, J. Pharm. Sci.108 (2019) 620–629; https://doi.org/10.1016/J.XPHS.2018.10.03410.1016/j.xphs.2018.10.034
  21. 21. H. Qu, J. Wang, Y. Wu, J. Zheng, Y. S. R. Krishnaiah, M. Absar, S. Choi, M. Ashraf, C. N. Cruz and X. Xu, Asymmetric flow field flow fractionation for the characterization of globule size distribution in complex formulations: A cyclosporine ophthalmic emulsion case, Int. J. Pharm.538 (2018) 215–222; https://doi.org/10.1016/J.IJPHARM.2018.01.01210.1016/j.ijpharm.2018.01.012
  22. 22. T. J. Wooster, M. Golding and P. Sanguansri, Impact of Oil Type on Nanoemulsion Formation and Ostwald Ripening Stability, Langmuir24 (2008) 12758–12765; https://doi.org/10.1021/la801685v10.1021/la801685v
  23. 23. S. Uluata, E. A. Decker and D. J. McClements, Optimization of Nanoemulsion Fabrication Using Microfluidization: Role of Surfactant Concentration on Formation and Stability, Food Biophys.11 (2016) 52–59; https://doi.org/10.1007/s11483-015-9416-110.1007/s11483-015-9416-1
  24. 24. H. D. Silva, M. A. Cerqueira and A. A. Vicente, Influence of surfactant and processing conditions in the stability of oil-in-water nanoemulsions, J. Food Eng.167 (2015) 89–98; https://doi.org/10.1016/j.jfoodeng.2015.07.03710.1016/j.jfoodeng.2015.07.037
  25. 25. S. Brösel and H. Schubert, Investigations on the role of surfactants in mechanical emulsification using a high-pressure homogenizer with an orifice valve, Chem. Eng. Process. Process Intensif.38 (1999) 533–540; https://doi.org/10.1016/S0255-2701(99)00050-110.1016/S0255-2701(99)00050-1
  26. 26. J.-P. Hsu and A. Nacu, Behavior of soybean oil-in-water emulsion stabilized by nonionic surfactant, J. Colloid Interface Sci.259 (2003) 374–381; https://doi.org/10.1016/S0021-9797(02)00207-210.1016/S0021-9797(02)00207-2
  27. 27. J. M. Tiffany, N. Winter and G. Bliss, Tear film stability and tear surface tension, Curr. Eye Res.8 (1989) 507–515; https://doi.org/10.3109/0271368890900003110.3109/02713688909000031
  28. 28. B. Nagyová and J. M. Tiffany, Components responsible for the surface tension of human tears, Curr. Eye Res.19 (1999) 4–11; https://doi.org/10.1076/ceyr.19.1.4.534110.1076/ceyr.19.1.4.5341
  29. 29. A. Puinhas, P. Sampaio, E. M. S. Castanheira, M. E. C. D. Real Oliveira and M. Lira, Comparison of IgA, TNF-α and surface tension of the tear film in two different times of the day, Contact Lens Anterior Eye36 (2013) 140–145; https://doi.org/10.1016/J.CLAE.2012.12.00510.1016/j.clae.2012.12.005
  30. 30. M. Hotujac Grgurević, M. Juretić, A. Hafner, J. Lovrić and I. Pepić, Tear fluid-eye drops compatibility assessment using surface tension, Drug Dev. Ind. Pharm.43 (2017) 275–282; https://doi.org/10.1080/03639045.2016.123892410.1080/03639045.2016.1238924
  31. 31. A. Ludwig and H. Reimann, Eye BT – Practical Pharmaceutics: An International Guideline for the Preparation, Care and Use of Medicinal Products, In Y. Bouwman-Boer, V. Fenton-May, & P. Le Brun (Eds.), (pp. 163–188). Cham: Springer International Publishing; https://doi.org/10.1007/978-3-319-15814-3_1010.1007/978-3-319-15814-3_10
  32. 32. K. A. Fitzgerald, M. Malhotra, C. M. Curtin, F. J. O’ Brien and C. M. O’ Driscoll, Life in 3D is never flat: 3D models to optimise drug delivery, J. Control. Release215 (2015) 39–54; https://doi.org/10.1016/J.JCONREL.2015.07.02010.1016/j.jconrel.2015.07.020
  33. 33. M. Ruponen and A. Urtti, Undefined role of mucus as a barrier in ocular drug delivery, Eur. J. Pharm. Biopharm.96 (2015) 442–446; https://doi.org/10.1016/J.EJPB.2015.02.03210.1016/j.ejpb.2015.02.032
  34. 34. I. Pepić, J. Lovrić, B. Cetina-Čižmek, S. Reichl and J. Filipović-Grčić, Toward the practical implementation of eye-related bioavailability prediction models, Drug Discov. Today19 (2014) 31–44; https://doi.org/10.1016/J.DRUDIS.2013.08.00210.1016/j.drudis.2013.08.002
  35. 35. I. Krtalić, S. Radošević, A. Hafner, M. Grassi, M. Nenadić, B. Cetina-Čižmek, J. Filipović-Grčić, I. Pepić and J. Lovrić, D-Optimal Design in the Development of Rheologically Improved In Situ Forming Ophthalmic Gel, J. Pharm. Sci.107 (2018) 1562–1571; https://doi.org/10.1016/J.XPHS.2018.01.01910.1016/j.xphs.2018.01.019
  36. 36. J. Bassi da Silva, S. B. de S. Ferreira, O. de Freitas and M. L. Bruschi, A critical review about methodologies for the analysis of mucoadhesive properties of drug delivery systems, Drug Dev. Ind. Pharm.43 (2017) 1053–1070; https://doi.org/10.1080/03639045.2017.129460010.1080/03639045.2017.1294600
  37. 37. E. E. Hassan and J. M. Gallo, A Simple Rheological Method for the in Vitro Assessment of Mucin-Polymer Bioadhesive Bond Strength, Pharm. Res. An Off. J. Am. Assoc. Pharm. Sci. (1990); https://doi.org/10.1023/A:101581261563510.1023/A:1015812615635
DOI: https://doi.org/10.2478/acph-2019-0054 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 621 - 634
Accepted on: Jul 10, 2019
|
Published on: Oct 21, 2019
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2019 Bisera Jurišić Dukovski, Ana Bračko, Marija Šare, Ivan Pepić, Jasmina Lovrić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.